Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

A novel cellular RNA helicase, RH116, differentially regulates cell growth, programmed cell death and human immunodeficiency virus type 1 replication.

Cocude C, Truong MJ, Billaut-Mulot O, Delsart V, Darcissac E, Capron A, Mouton Y, Bahr GM.

J Gen Virol. 2003 Dec;84(Pt 12):3215-25.

PMID:
14645903
2.

Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice.

Bahr GM, Darcissac EC, Castéran N, Amiel C, Cocude C, Truong MJ, Dewulf J, Capron A, Mouton Y.

J Virol. 2001 Aug;75(15):6941-52.

3.
4.

mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties.

Kang DC, Gopalkrishnan RV, Wu Q, Jankowsky E, Pyle AM, Fisher PB.

Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):637-42.

5.

The RNA helicase DDX1 is involved in restricted HIV-1 Rev function in human astrocytes.

Fang J, Acheampong E, Dave R, Wang F, Mukhtar M, Pomerantz RJ.

Virology. 2005 Jun 5;336(2):299-307.

6.

[Use of the expression coefficient to evaluate the effect of various substances on HIV-1 in vitro].

Krivorutchenko IuL.

Mikrobiol Z. 2000 Nov-Dec;62(6):33-9. Russian.

PMID:
11247348
8.

A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev.

Fang J, Kubota S, Yang B, Zhou N, Zhang H, Godbout R, Pomerantz RJ.

Virology. 2004 Dec 20;330(2):471-80.

9.

P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages.

Burdick R, Smith JL, Chaipan C, Friew Y, Chen J, Venkatachari NJ, Delviks-Frankenberry KA, Hu WS, Pathak VK.

J Virol. 2010 Oct;84(19):10241-53. doi: 10.1128/JVI.00585-10. Epub 2010 Jul 28.

10.

Antiretroviral effects of deoxyhypusyl hydroxylase inhibitors: a hypusine-dependent host cell mechanism for replication of human immunodeficiency virus type 1 (HIV-1).

Andrus L, Szabo P, Grady RW, Hanauske AR, Huima-Byron T, Slowinska B, Zagulska S, Hanauske-Abel HM.

Biochem Pharmacol. 1998 Jun 1;55(11):1807-18.

PMID:
9714299
11.

Intracellular expression of RNA transcripts complementary to the human immunodeficiency virus type 1 gag gene inhibits viral replication in human CD4+ lymphocytes.

Veres G, Escaich S, Baker J, Barske C, Kalfoglou C, Ilves H, Kaneshima H, Böhnlein E.

J Virol. 1996 Dec;70(12):8792-800.

12.

Comparative analyses of intracellularly expressed antisense RNAs as inhibitors of human immunodeficiency virus type 1 replication.

Veres G, Junker U, Baker J, Barske C, Kalfoglou C, Ilves H, Escaich S, Kaneshima H, Böhnlein E.

J Virol. 1998 Mar;72(3):1894-901.

13.

The requirement of the DEAD-box protein DDX24 for the packaging of human immunodeficiency virus type 1 RNA.

Ma J, Rong L, Zhou Y, Roy BB, Lu J, Abrahamyan L, Mouland AJ, Pan Q, Liang C.

Virology. 2008 May 25;375(1):253-64. doi: 10.1016/j.virol.2008.01.025. Epub 2008 Mar 4.

14.

Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication.

Steinkasserer A, Harrison R, Billich A, Hammerschmid F, Werner G, Wolff B, Peichl P, Palfi G, Schnitzel W, Mlynar E, et al.

J Virol. 1995 Feb;69(2):814-24.

15.

Hepatitis C virus core protein interacts with cellular putative RNA helicase.

You LR, Chen CM, Yeh TS, Tsai TY, Mai RT, Lin CH, Lee YH.

J Virol. 1999 Apr;73(4):2841-53.

16.

Muramyl dipeptide inhibits replication of human immunodeficiency virus in vitro.

Masihi KN, Lange W, Rohde-Schulz B, Chedid L.

AIDS Res Hum Retroviruses. 1990 Mar;6(3):393-9.

PMID:
2111159
17.

Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells.

Saleh S, Wightman F, Ramanayake S, Alexander M, Kumar N, Khoury G, Pereira C, Purcell D, Cameron PU, Lewin SR.

Retrovirology. 2011 Oct 12;8:80. doi: 10.1186/1742-4690-8-80.

18.

Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.

Lapenta C, Santini SM, Proietti E, Rizza P, Logozzi M, Spada M, Parlato S, Fais S, Pitha PM, Belardelli F.

Virology. 1999 Oct 10;263(1):78-88.

20.

Clinical tolerance and immunologic effects after single or repeated administrations of the synthetic immunomodulator murabutide in HIV-1-infected patients.

Amiel C, De La Tribonnière X, Vidal V, Darcissac E, Mouton Y, Bahr GM.

J Acquir Immune Defic Syndr. 2002 Jul 1;30(3):294-305.

PMID:
12131566

Supplemental Content

Support Center